These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34239507)

  • 1. Tapping Into Actinobacterial Genomes for Natural Product Discovery.
    Singh TA; Passari AK; Jajoo A; Bhasin S; Gupta VK; Hashem A; Alqarawi AA; Abd Allah EF
    Front Microbiol; 2021; 12():655620. PubMed ID: 34239507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of Secondary Metabolism of Hypogean Actinobacterial Genera to Chemical and Biological Stimuli.
    Covington BC; Spraggins JM; Ynigez-Gutierrez AE; Hylton ZB; Bachmann BO
    Appl Environ Microbiol; 2018 Oct; 84(19):. PubMed ID: 30030223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic Distribution of Secondary Metabolites in the Bacillus subtilis Species Complex.
    Steinke K; Mohite OS; Weber T; Kovács ÁT
    mSystems; 2021 Mar; 6(2):. PubMed ID: 33688015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-Scale Bioinformatics Analysis of
    Grubbs KJ; Bleich RM; Santa Maria KC; Allen SE; Farag S; ; Shank EA; Bowers AA
    mSystems; 2017; 2(6):. PubMed ID: 29152584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in
    Nguyen CT; Dhakal D; Pham VTT; Nguyen HT; Sohng JK
    Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32344564
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Brotherton CA; Medema MH; Greenberg EP
    mSystems; 2018; 3(3):. PubMed ID: 29600287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endophytic actinobacteria: Diversity, secondary metabolism and mechanisms to unsilence biosynthetic gene clusters.
    Dinesh R; Srinivasan V; T E S; Anandaraj M; Srambikkal H
    Crit Rev Microbiol; 2017 Sep; 43(5):546-566. PubMed ID: 28358596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing rare marine actinomycete genomes reveals high density of unique natural product biosynthetic gene clusters.
    Schorn MA; Alanjary MM; Aguinaldo K; Korobeynikov A; Podell S; Patin N; Lincecum T; Jensen PR; Ziemert N; Moore BS
    Microbiology (Reading); 2016 Dec; 162(12):2075-2086. PubMed ID: 27902408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biotechnological aspects of secondary metabolites in actinobacteria.
    Salwan R; Sharma V
    Microbiol Res; 2020 Jan; 231():126374. PubMed ID: 31756597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites.
    Bader CD; Panter F; Müller R
    Biotechnol Adv; 2020; 39():107480. PubMed ID: 31707075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Approaches to Detect Biosynthetic Gene Clusters in the Environment.
    Chen R; Wong HL; Burns BP
    Medicines (Basel); 2019 Feb; 6(1):. PubMed ID: 30823559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance Gene-Directed Genome Mining of 50
    Kjærbølling I; Vesth T; Andersen MR
    mSystems; 2019; 4(4):. PubMed ID: 31098395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenomic Analysis of Natural Products Biosynthetic Gene Clusters Allows Discovery of Arseno-Organic Metabolites in Model Streptomycetes.
    Cruz-Morales P; Kopp JF; Martínez-Guerrero C; Yáñez-Guerra LA; Selem-Mojica N; Ramos-Aboites H; Feldmann J; Barona-Gómez F
    Genome Biol Evol; 2016 Jul; 8(6):1906-16. PubMed ID: 27289100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators.
    Martinet L; Naômé A; Deflandre B; Maciejewska M; Tellatin D; Tenconi E; Smargiasso N; de Pauw E; van Wezel GP; Rigali S
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?
    Genilloud O
    Antibiotics (Basel); 2018 Sep; 7(4):. PubMed ID: 30257490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonribosomal peptides in fungal cell factories: from genome mining to optimized heterologous production.
    Vassaux A; Meunier L; Vandenbol M; Baurain D; Fickers P; Jacques P; Leclère V
    Biotechnol Adv; 2019 Dec; 37(8):107449. PubMed ID: 31518630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding and manipulating antibiotic production in actinomycetes.
    Bibb MJ
    Biochem Soc Trans; 2013 Dec; 41(6):1355-64. PubMed ID: 24256223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Products and the Gene Cluster Revolution.
    Jensen PR
    Trends Microbiol; 2016 Dec; 24(12):968-977. PubMed ID: 27491886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergizing the potential of bacterial genomics and metabolomics to find novel antibiotics.
    Panter F; Bader CD; Müller R
    Chem Sci; 2021 Mar; 12(17):5994-6010. PubMed ID: 33995996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.